Trends of Anti-adhesion Adjuvant - Review

유착 방지제의 현황

  • Oh, Ae-Gyeong (Department of Organic Material Science and Engineering, Pusan National University)
  • 오애경 (부산대학교 공과대학 유기소재시스템공학과)
  • Received : 2013.11.19
  • Accepted : 2013.11.20
  • Published : 2013.12.01

Abstract

Adhesions are one of the most complications of surgery, and the leading cause of infertility, chronical pain and potentially intestinal obstruction. As the frequency of operation increases, prevention of adhesion formation has become a task to overcome in surgical research. A number of adjuvant have been investigated, including both pharmaceutical agents and physical barriers for adhesion prevention. Pharmaceutical agents and adhesion barrier have reduced adhesion formation in clinical practices to certain degrees, however, complete prevention of adhesions has yet to be overcome. In this review, the anti-adhesion agents were categorized into their uses and described of the properties of products commercially available. The purpose of this article is to review the current state of adhesion development and the effects of adhesion agents in prevention of adhesions.

Keywords

References

  1. W. Arung, M. Meurisse, et al, "Pathophysiology and prevention of postoperative peritoneal adhesions", World J. Gastro., 17, 4545 (2011). https://doi.org/10.3748/wjg.v17.i41.4545
  2. B. W. J. Hellebrekers and T. Kooistra, "Pathogenesis of postoperative adhesion formation", Br. J. Surg., 98, 1503 (2011). https://doi.org/10.1002/bjs.7657
  3. A. Imai, H. Takagi et al, "Non-barrier agents for postoperative adhesion prevention : clinical and preclinical aspects", Arch Gynecol. Obstet., 282, 269 (2010). https://doi.org/10.1007/s00404-010-1423-3
  4. K. Falk, P. Bjorquist, M. Stromquist, "Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type", Br. J. Surg., 99, 286 (2001).
  5. Y. Yeo, E. Bellas, "Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit model", Biomaterials, 28, 3704 (2007). https://doi.org/10.1016/j.biomaterials.2007.04.033
  6. K. E. Rodgers, W. Girgis, R. Lilford, "Reduction of adhesion formation by intraperitoneal administration of anti-inflammatory peptide 2", J. Invest Surg., 10, 31 (1997). https://doi.org/10.3109/08941939709032122
  7. A. Watson, P Vandekerckhove, et al, "Liquid and fluid agents for preventing adhesions after surgery for subfertility", Cochrane Database Syst. Rev., (2000).
  8. T. Kucukozkan, B. Ersoy, et al, "Prevention of adhesions by sodium chromoglycate, dexamethasone, saline and aprotinin after pelvic surgery", ANZ J. Surg., 74, 1111 (2004). https://doi.org/10.1111/j.1445-1433.2004.03261.x
  9. C. C Buckenmaier, A.E Pusateri, et al, "Comparison of antiadhesive treatments using an objective rat model", Am. Surg., 65, 274 (1999).
  10. Practice Committee of the American Society for Reproductive Medicine, "Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery", Fertil. Steril., 88, 21 (2007). https://doi.org/10.1016/j.fertnstert.2007.04.066
  11. J Kutlay, Y Ozer, et al, "Comparative effectiveness of several agents for preventing postoperative adhesions", World J. Surg., 28, 662 (2004). https://doi.org/10.1007/s00268-004-6825-6
  12. R. P. Jansen, "Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions", Surg. Gynecol. Obstet., 166, 154 (1988).
  13. S. M. Chowdhury and J. A Hubbell, "Adhesion prevention with ancrod release via a tissue-adherent hydrogel", J. Surg. Res., 61, 58 (1996). https://doi.org/10.1006/jsre.1996.0081
  14. L. Holmdahl, "The role of fibrinolysis in adhesion formation", Eur. J. Surg. Suppl., 577, 24 (1997).
  15. G. S. di Zerega, "Gontemporary adhesion prevention", Fertil. Steril., 61, 219 (1994).
  16. K. E. Rodgers, G. S di Zerega, "Developing pharmacologic agents for adhesion prevention", Springer-Verlag, New York, 441 (2000).
  17. J. L. Hill-West, R.C. Dunn, et al, "Local release of fibrinolytic agents for adhesion prevention", J. Surg. Res., 59, 759 (1995). https://doi.org/10.1006/jsre.1995.1236
  18. L. E. Holmdahl, M. Al-Jabreen, et al, "Role of fibrinolysis in the formation of postoperative adhesions", Wound Rep. Reg., 2, 171 (1994). https://doi.org/10.1046/j.1524-475X.1994.20306.x
  19. D. Menzies, H. Ellis, "The role of plasminogen activator in adhesion prevention", Surg., Gynecol. & Obstet., 172, 362 (1991).
  20. J. N. Gutmann, M. P. Diamond, "Principles of laparoscopic microsurgery and adhesion prevention", New York, Springer, 55 (1992).
  21. J. N. Gutmann, A. S Penzias, et al, "Adhesions in reproductive surgery", St. Louis, Mosby, 681 (1995).
  22. Y. Liu, H. Li et al, "Crosslinked hyaluronan hydrogels containing mitomycin C reduce postoperative abdominal adhesions", Fertil. Steril., 83, 1275 (2005). https://doi.org/10.1016/j.fertnstert.2004.09.038
  23. Y. Yeo, D. S. Kohane, "Polymer in the prevention of peritoneal adhesions", Eur. J. Pharm. Biopharm., 68, 57 (2008). https://doi.org/10.1016/j.ejpb.2007.03.027
  24. R. M. Kamel, "Prevention of postoperative peritoneal adhesions", Eur. J. Obstet. & Gynecol. and Rep. Biol., 150, 111 (2010). https://doi.org/10.1016/j.ejogrb.2010.02.003
  25. J. H. Lee, H. Y. Kim et al, "Recent R&D Trends of Medical Adhesives and Anti-adhesion Membranes", Biomaterials Research, 14, 66 (2010).
  26. G. S. di Zerega, S. J. Verco, et al, "A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction adhesions following laparoscopic gynaecological surgery", Hum. Reprod., 17, 1031 (2002). https://doi.org/10.1093/humrep/17.4.1031
  27. K. Hosie, J. A. Gilbert, et al, "Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin", Drug Delivery, 8, 9 (2001). https://doi.org/10.1080/107175401300002694
  28. D. Menzies, M. H. Pascual, "Use of icodextrin 4% solution in the prevention of adhesion formation following general surgery: from the multicentre ARIEL Registry", Ann. R. Coll. Surg. Engl., 88, 375 (2006). https://doi.org/10.1308/003588406X114730
  29. G. S. di Zerega, "Use of adhesion prevention barriers in pelvic reconstructive and gynecologic surgery", New York: Springer-Verlag, 379 (2000).
  30. C. K. Sites, B. A. Jensen, et al, "Transvaginal ultrasonographic assessment of Hyskon or lactated Ringer's solution instillation after laparoscopy: Randomized, controlled study", J. Ultrasound Med., 16, 195 (1997).
  31. M. Diamond, "Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study", Fertil. Steril., 69, 1067 (1998). https://doi.org/10.1016/S0015-0282(98)00057-0
  32. D. Al-Jaroudi, T. Tulandi, Adhesion prevention in gynecologic surgery, Obstet. Gynecol. Surg., 59, 360 (2004). https://doi.org/10.1097/00006254-200405000-00024
  33. J. W Burns, K, Skinner, et al, "Prevention of tissue injury and postsurgical adhesions by precoating tissues with hyaluronic acid solutions", J. Surg. Res., 59, 644 (1995). https://doi.org/10.1006/jsre.1995.1218
  34. M. Korrel, "Endometriosis: a common cause of pelvic pain", Adhes. News Views, 5, 18 (2004).
  35. R. Ferland, D. Mulani, et al, "Evaluation of a sprayable polyethylene glycol adhesion barrier in a porcine efficacy model", Hum. Reprod., 16, 2718 (2001). https://doi.org/10.1093/humrep/16.12.2718
  36. www.biorane.com
  37. M. Diamond, "Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study, Seprafilm Adhesion Study Group", Fertil. Steril., 66, 904 (1996).
  38. W. Vrijland, L. Tseng, et al, "Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial", Ann. Surg., 235, 193 (2002). https://doi.org/10.1097/00000658-200202000-00006
  39. C. Kinsky and T. Cunningham, U. S. Patent, 4,840,626 (1989).
  40. www.mastbio.com
  41. Frost and Sullivan, U.S. markets for hemostats-tissue sealant-tissue adhesive and adhesion prevention products in December. 2004
  42. M. P. Diamond, E. L. Burns, "Seprafilm adhesion barrier (1)", Genecol. Surg., 9, 237 (2012) https://doi.org/10.1007/s10397-012-0741-9
  43. M. P. Diamond, E. L. Burns, "Seprafilm adhesion barrier (2)", Genecol. Surg., 9, 247 (2012) https://doi.org/10.1007/s10397-012-0742-8
  44. H. Lamoutte, R. Chatterji, "SurgiWrap(R), Mast bioresorbable sheet use for the prevention of soft tissue attachment; a two year experience", Biomaterials / Bioresorbable Technol., Mast Biosurgery (2005).
  45. K. Sekiba, "Use of Interceed(TC7) absorbable adhesion barrier to reduce postoperative adhesion reformation in infertility and endometriosis surgery", Obstet. Gynecol., 79, 518 (1992).
  46. INTERCEED(TC7) Adhesion Barrier Study Group, "Prevention of postsurgical adhesions by INTERCEED(TC7), an absorbable adhesion barrier: a prospective randomized multicenter clinical study", Fertil. Steril., 51, 933 (1989).
  47. G. M. Boland, R. J. Weigel, "Formation and prevention of postoperative abdominal adhesions", J. Surg. Res., 132, 3 (2006). https://doi.org/10.1016/j.jss.2005.12.002
  48. K. Pagidas, T. Tulandi, "Effects of Ringer's lactate, interceed(TC7) and Gore-Tex surgical membrane on postsurgical adhesion formation", Fertil. Steril., 57, 199 (1992).
  49. R. L. Reid, P. M. Hahn, et al, "A randomised clinical trial of oxidized regenerated cellulose adhesion barrier (Interceed, TC7) alone or in combination with heparin," Fertil. Steril., 67, 23 (1997). https://doi.org/10.1016/S0015-0282(97)81850-X
  50. C. M. March, S. Boyers, et al, "Prevention of adhesion formation/reformation with the Gore-Tex surgical membrane", Prog. Clin. Biol. Res., 381, 253 (1993).
  51. 이영우, 추보영, et al, "가토 모델에서 복강경 수술 시 전기방사 나노섬유 유착방지제의 효과 및 안전성", 대한외과학회지, 76, 73 (2009).
  52. A. Johns, "Evidence-based prevention of postoperative adhesions", Hum. Reprod. Update, 7, 577 (2001). https://doi.org/10.1093/humupd/7.6.577